Skip to Content

User Reviews for Tilmanocept

Also known as: Lymphoseek

Condition Avg. Rating Reviews Compare
Diagnosis and Investigation  
1 reviews 80 medications

Reviews may be moderated or edited before publication to correct grammar and spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest in the medication will not be published. As reviews and ratings are subjective and self-reported, this information should not be used as the basis for any statistical analysis or scientific studies.

B Anderson, MD · Taken for less than 1 month June 27, 2013

Lymphoseek (tilmanocept) for Diagnosis and Investigation: “Conduced first exploratory use in June, 2013 indication cutaneous melanoma, Breslow/3mm. Tilmanocept was well received by the patient with no local. Clearance delay provision <20 min. SLN discovery total <4 min/2 SLN/Path.”

10 / 10

This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.